By using a blocking antibody against IL-23, we were able to prevent the development of insulin resistance and NAFLD in Atg5 CD11cKO mice, suggesting that autophagy deletion causes IL-23 induction, resulting in metabolic derangements contributing to these distinct but related conditions. The gene discussed is ATG5; the disease is metabolic dysfunction-associated steatotic liver disease.